Urocortin 2 role in placental and myometrial inflammatory mechanisms at parturition

Endocrinology (United States)

Volumn 156, Issue 2, 2015, Pages 670-679

  Voltolini, Chiara ^a   Battersby, Sharon ^b   Novembri, Romina ^a   Torricelli, Michela ^a   Severi, Filiberto M ^a   Petraglia, Felidce ^a   Norman, Jane E ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN F2 ALPHA RECEPTOR; PROSTAGLANDIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UROCORTIN II; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYTOKINE; PROSTAGLANDIN F2ALPHA RECEPTOR; PTGS2 PROTEIN, HUMAN; UCN2 PROTEIN, HUMAN; UROCORTIN; UROCORTIN 2, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIRTH; CESAREAN SECTION; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTIVE SURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS MEMBRANE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABOR ONSET; MOUSE; MYOMETRIUM; NONHUMAN; PLACENTA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; UTERUS CONTRACTILITY; UTERUS CONTRACTION; VAGINAL DELIVERY; ANIMAL; CELL LINE; IMMUNOLOGY; LABOR; METABOLISM; PHYSIOLOGY; PREGNANCY;

ANIMALS; CELL LINE; CORTICOTROPIN-RELEASING HORMONE; CYCLOOXYGENASE 2; CYTOKINES; FEMALE; HUMANS; LABOR, OBSTETRIC; MICE; MYOMETRIUM; NF-KAPPA B; PARTURITION; PLACENTA; PREGNANCY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, PROSTAGLANDIN; TUMOR NECROSIS FACTOR-ALPHA; UROCORTINS; UTERINE CONTRACTION;

EID: 84921695013     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1432     Document Type: Article

References (28)

1. Petraglia F, Imperatore A, Challis JR. Neuroendocrine mechanisms in pregnancy and parturition. Endocr Rev. 2010;31:783-816.
2. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nat Med. 1995;1:460-463.
3. Aguilera G, Nikodemova M, Wynn PC, Catt KJ. Corticotropin releasing hormone receptors: two decades later. Peptides. 2004;25: 319e29.
4. Hsu SY, Hsueh AJ. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med. 2001;7:605-611.
5. Imperatore A, Florio P, Torres PB, et al. Urocortin 2 and urocortin 3 are expressed by the human placenta, deciduas, and fetal membranes. Am J Obstet Gynecol. 2006;195:288-295.
6. Karteris E, Hillhouse EW, Grammatopoulos D. Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin- releasing hormone receptor in the control of myometrial contractility. Endocrinology. 2004;145:890-900.
7. Imperatore A, Li W, Petraglia F, Challis JR. Urocortin 2 stimulates estradiol secretion from cultured human placental cells: an effect mediated by the type 2 corticotrophin-releasing hormone (CRH) receptor. Reprod Sci. 2009;16:551e8.
8. Gao L, Lu C, Xu C, Tao Y, Cong B, Ni X. Differential regulation of prostaglandin production mediated by corticotropin-releasing hormone receptor type 1 and type 2 in cultured human placental trophoblasts. Endocrinology. 2008;149:2866-2876.
9. Novembri R, Torricelli M, Bloise E, et al. Effects of urocortin 2 and urocortin 3 on IL-10 and TNF-expression and secretion from human trophoblast explants. Placenta. 2011;32:969-974.
10. Ikeda K, Tojo K, Inada Y, et al. Regulation of urocortin I and its related peptide urocortin II by inflammatory and oxidative stresses in HL-1 cardiomyocytes. J Mol Endocrinol. 2009;42:479-489.
11. Moss AC, Anton P, Savidge T, et al. Urocortin II mediates proinflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2. Gut. 2007;56:1210-1217.
12. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-C(T)) method. Methods. 2001;25:402-408.
13. Ghashghaeinia M, Toulany M, Saki M, et al. The NF-B pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated erythrocytes. Cell Physiol Biochem. 2011;27: 45-54.
14. Dallot E, Pouchelet M, Gouhier N, Cabrol D, Ferré F, Breuiller- Fouché M. Contraction of cultured human uterine smooth muscle cells after stimulation with endothelin-1. Biol Reprod. 2003;68: 937-942.
15. Hutchinson JL, Rajagopal SP, Yuan M, Norman JE. Lipopolysaccharide promotes contraction of uterine myocytes via activation of Rho/ROCK signaling pathways. FASEB J. 2014;28:94-105.
16. Golightly E, Jabbour HN, Norman JE. Endocrine immune interactions in human parturition. Mol Cell Endocrinol. 2011;335:52-59.
17. Tribe RM, Moriarty P, Dalrymple A, Hassoni AA, Poston L. Interleukin- 1 induces calcium transients and enhances basal and store operated calcium entry in human myometrial smooth muscle. Biol Reprod. 2003;68:1842-1849.
18. Osman I, Young A, Ledingham MA, et al. Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod. 2003;9:41-45.
19. Norman JE, Bollapragada S, Yuan M, Nelson SM. Inflammatory pathways in the mechanism of parturition. BMC Pregnancy Childbirth. 2007;7:S7.
20. Sennström MB, Ekman G, Westergren-Thorsson G, et al. Human cervical ripening, an inflammatory process mediated by cytokines. Mol Hum Reprod. 2000;6:375-381.
21. Elliott CL, Slater DM, Dennes W, Poston L, Bennett PR. Interleukin 8 expression in human myometrium: changes in relation to labor onset and with gestational age. Am J Reprod Immunol. 2000;43: 272-277.
22. Torricelli M, Novembri R, Bloise E, De Bonis M, Challis JR, Petraglia F. Changes in placental CRH, urocortins, and CRH-receptor mRNA expression associated with preterm delivery and chorioamnionitis. J Clin Endocrinol Metab. 2011;96:534-540.
23. Christiaens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchell BF, Olson DM. Inflammatory processes in preterm and term parturition. J Reprod Immunol. 2008;79:50-57.
24. Zhang LM, Wang YK, Hui N, et al. Corticotropin-releasing hormone acts on CRH-R1 to inhibit the spontaneous contractility of non-labouring human myometrium at term. Life Sci. 2008;83:620-624.
25. Belt AR, Baldassare JJ, Molnár M, Romero R, Hertelendy F. The nuclear transcription factor NF-B mediates interleukin-1-induced expression of cyclooxygenase-2 in human myometrial cells. Am J Obstet Gynecol. 1999;181:359-366.
26. Hertelendy F, Romero R, Molnár M, Todd H, Baldassare JJ. Cytokine- initiated signal transduction in human myometrial cells. Am J Reprod Immunol. 1993;30:49-57.
27. Molnár M, Romero R, Hertelendy F. Interleukin-1 and tumor necrosis factor stimulate arachidonic acid release and phospholipid metabolism inhumanmyometrial cells.AmJ Obstet Gynecol. 1993; 169:825-829.
28. Rauk PN, Chiao JP. Interleukin-1 stimulates human uterine prostaglandin production through induction of cyclooxygenase-2 expression. Am J Reprod Immunol. 2000;43:152-159.